These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29736457)

  • 21. Randomized trial comparing two natural surfactants (Survanta vs. bLES) for treatment of neonatal respiratory distress syndrome.
    Lam BC; Ng YK; Wong KY
    Pediatr Pulmonol; 2005 Jan; 39(1):64-9. PubMed ID: 15558604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acute effects on systemic circulation after intratracheal instillation of Curosurf or Survanta in surfactant-depleted newborn piglets.
    Moen A; Yu XQ; Almaas R; Curstedt T; Saugstad OD
    Acta Paediatr; 1998 Mar; 87(3):297-303. PubMed ID: 9560037
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural vs synthetic surfactants in neonatal respiratory distress syndrome.
    Halliday HL
    Drugs; 1996 Feb; 51(2):226-37. PubMed ID: 8808165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The short-term outcome of a large cohort of very preterm infants treated with poractant alfa (Curosurf) for respiratory distress syndrome. A postmarketing phase IV study.
    Lamboley-Gilmert G; Lacaze-Masmonteil T;
    Paediatr Drugs; 2003; 5(9):639-45. PubMed ID: 12956620
    [TBL] [Abstract][Full Text] [Related]  

  • 27. One-year follow-up of very preterm infants who received lucinactant for prevention of respiratory distress syndrome: results from 2 multicenter randomized, controlled trials.
    Moya F; Sinha S; Gadzinowski J; D'Agostino R; Segal R; Guardia C; Mazela J; Liu G;
    Pediatrics; 2007 Jun; 119(6):e1361-70. PubMed ID: 17533176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A unique story in neonatal research: the development of a porcine surfactant.
    Curstedt T; Halliday HL; Speer CP
    Neonatology; 2015; 107(4):321-9. PubMed ID: 26044099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Prevention and treatment of respiratory distress syndrome in premature infants using intratracheally administered surfactants].
    de Winter JP; Egberts J; de Kleine MJ; van Bel F; Wijnands JB; Guit GL
    Ned Tijdschr Geneeskd; 1992 Oct; 136(41):2018-24. PubMed ID: 1407193
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylaxis of respiratory distress syndrome by treatment with modified porcine surfactant at birth: a multicentre prospective randomized trial.
    Bevilacqua G; Parmigiani S; Robertson B
    J Perinat Med; 1996; 24(6):609-20. PubMed ID: 9120744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
    Bancalari E
    Am J Perinatol; 2004 Jul; 21(5):307-9. PubMed ID: 15232767
    [No Abstract]   [Full Text] [Related]  

  • 32. Comparative efficacy of pulmonary surfactant in respiratory distress syndrome in preterm infants: a Bayesian network meta-analysis.
    Qiu C; Ma C; Fan N; Zhang X; Zheng G
    Arch Med Sci; 2023; 19(5):1446-1453. PubMed ID: 37732036
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H; Xu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome.
    Liechty EA; Donovan E; Purohit D; Gilhooly J; Feldman B; Noguchi A; Denson SE; Sehgal SS; Gross I; Stevens D
    Pediatrics; 1991 Jul; 88(1):19-28. PubMed ID: 2057268
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.
    Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS
    Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome.
    Fujii AM; Patel SM; Allen R; Doros G; Guo CY; Testa S
    J Perinatol; 2010 Oct; 30(10):665-70. PubMed ID: 20336076
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of clinical trials comparing natural and synthetic surfactants.
    Halliday HL
    Biol Neonate; 1995; 67 Suppl 1():32-47. PubMed ID: 7647157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Improved neonatal survival following multiple doses of bovine surfactant in very premature neonates at risk for respiratory distress syndrome.
    Hoekstra RE; Jackson JC; Myers TF; Frantz ID; Stern ME; Powers WF; Maurer M; Raye JR; Carrier ST; Gunkel JH
    Pediatrics; 1991 Jul; 88(1):10-8. PubMed ID: 2057245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mortality risk factors in premature infants with respiratory distress syndrome treated by mechanical ventilation].
    Fidanovski D; Milev V; Sajkovski A; Hristovski A; Sofijanova A; Kojić L; Kimovska M
    Srp Arh Celok Lek; 2005; 133(1-2):29-35. PubMed ID: 16053172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome.
    Dizdar EA; Sari FN; Aydemir C; Oguz SS; Erdeve O; Uras N; Dilmen U
    Am J Perinatol; 2012 Feb; 29(2):95-100. PubMed ID: 22105435
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.